12 insiders reported 53 Form 4 transactions for Regulus Therapeutics Inc. (RGLS) over the past 18 months (most recent 2025-06-27). Recent activity: PAPADOPOULOS STELIOS (Director) Sell 976,253 shares, Huang Alice Shih-hou (Director) Sell 57,292 shares, RASTETTER WILLIAM H (Director) Sell 44,264 shares, RASTETTER WILLIAM H (Director) Sell 57,292 shares, Aker Christopher Ray (Sr. VP & General Counsel) Sell 60,796 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-27 | PAPADOPOULOS STELIOS | Director | Sell | 976,253 | $0 |
| 2025-06-27 | Huang Alice Shih-hou | Director | Sell | 57,292 | $0 |
| 2025-06-27 | RASTETTER WILLIAM H | Director | Sell | 44,264 | $0 |
| 2025-06-27 | RASTETTER WILLIAM H | Director | Sell | 57,292 | $0 |
| 2025-06-27 | Aker Christopher Ray | Sr. VP & General Counsel | Sell | 60,796 | $0 |
| 2025-06-27 | Aker Christopher Ray | Sr. VP & General Counsel | Sell | 83,125 | $0 |
| 2025-06-27 | Witz Pascale | Director | Sell | 67,233 | $0 |
| 2025-06-27 | PAPADOPOULOS STELIOS | Director | Sell | 64,635 | $0 |
| 2025-06-27 | Hagan Joseph P | Chief Executive Officer | Sell | 571,558 | $0 |
| 2025-06-27 | Nunn Jason Raleigh | Director | Sell | 62,500 | $0 |
| 2025-06-27 | CALSADA CRISPINA | Chief Financial Officer | Sell | 140,228 | $0 |
| 2025-06-27 | Rosen Hugh | Director | Sell | 6,979 | $0 |
| 2025-06-27 | Rosen Hugh | Director | Sell | 57,292 | $0 |
| 2025-06-27 | Collier Kathryn J | Director | Sell | 75,565 | $0 |
| 2025-06-27 | BALTIMORE DAVID | Director | Sell | 27,377 | $0 |
| 2025-06-27 | BALTIMORE DAVID | Director | Sell | 57,292 | $0 |
| 2025-06-27 | BALTIMORE DAVID | Director | Sell | 5,208 | $0 |
| 2025-06-27 | BALTIMORE DAVID | Director | Sell | 57,292 | $0 |
| 2025-06-27 | Huang Alice Shih-hou | Director | Sell | 5,208 | $0 |
| 2025-06-27 | Huang Alice Shih-hou | Director | Sell | 57,292 | $0 |
| 2025-06-27 | Huang Alice Shih-hou | Director | Sell | 27,377 | $0 |
| 2025-06-27 | Klassen Preston | President & Head of R & D | Sell | 115,555 | $0 |
| 2025-06-18 | Collier Kathryn J | Director | Buy | 1,396 | $13,820 |
| 2025-06-18 | Collier Kathryn J | Director | Buy | 2,604 | $25,780 |
| 2025-06-18 | Collier Kathryn J | Director | Buy | 2,325 | $20,460 |
Source: SEC Form 4 filings · as of 2025-06-27
